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Abstract
There is some evidence that periodontitis increases the risk of atherothrombosis. Abdominal aortic aneurysm (AAA) is a
cardiovascular disease with specific risk factors and physiopathological mechanisms that can lead to rupture in the absence
of treatment. The aim of the present systematic review was to explore the influence of periodontitis on the progression of
AAAs as a specific disease. A systematic search in PubMed/MEDLINE and Embase databases was performed. Human and
animal studies exploring the influence of periodontal pathogens on the progression of AAA were considered for inclusion.
After systematic screening, 5 articles were included in the review. Due to the heterogeneity of the selected studies, a meta-
analysis could not be performed. The descriptive analyses of the studies emphasized that periodontal pathogens or their
by-products contribute to systemic and local innate immunity likely to be associated with AAA physiopathology. Period-
ontitis seems to play a role in the development and progression of AAA. The present systematic review suggests that the
presence of periodontal bacteria in the bloodstream or in situ in the vascular lesion is a risk associated with aneurysmal
disease progression.
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Introduction
Abdominal aortic aneurysms (AAAs) are responsible for 1% to
3% of all deaths in Western countries among men aged 65 years
and older.1,2 The disease has genetic and environmental risk
factors such as smoking, older age, and male gender.3-5 The
estimated prevalence of AAA is between 1.3% and 12.5% in
men and 1.0% and 2.2 % in women. Abdominal aortic aneur-
ysm is a chronic degenerative disorder commonly associated
with an intraluminal thrombus (ILT)6 and with innate and adap-
tive immunities.7 The innate immunity is mainly represented
by the predominant presence of neutrophils in the ILT8 and
macrophages in the adventitia, and the adaptive one by the
presence of lymphoid tertiary organs in the adventitia.7 The
causes of the extracellular matrix (ECM) wall degradation
are enzymes mainly released by the ILT components (neu-
trophil elastase, matrix metallopeptidase 9 [MMP-9], and
plasmin).9
On the other hand, periodontitis, a chronic bacterial
aggression and inflammatory response of the periodon-
tium,10-12 affects 50% of the adult population.13,14 This
chronic multifactorial disease is characterized by the invasion
of gram-negative bacteria and their by-products in the period-
ontal tissues, leading to the destruction of the tooth support
and subsequently to tooth loss.15-20 The presence of period-
ontal pathogens leads to the degradation of the ECM; the
infiltration of neutrophils, macrophages, and lymphocytes;
and the production of proteases (MMPs and serine proteases),
resulting in progressive destruction of alveolar bone and
finally tooth loss.21-27
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Similar physiopathological mechanisms are found in period-
ontitis as occur in AAA: ECM destruction, innate and adaptive
immunity, and the role of proteolysis in the disease progres-
sion.28-37 There is consistent and strong epidemiologic evi-
dence that periodontitis imparts increased risk of future
cardiovascular disease (CVD; eg, atherosclerosis).38-42 Precli-
nical and clinical studies support the interaction between these
2 diseases. Tooth brushing, mastication, debridement, or scal-
ing can induce the passage of oral pathogens, their virulent
factors, or both into the bloodstream.43 It is believed that the
resulting transient or prolonged bacteremia can influence car-
diovascular pathogenesis. Periodontal pathogens, and more
specifically Porphyromonas gingivalis (Pg), have been found
in atherosclerotic plaques.44-50 These bacteria were also pres-
ent in the muscle tissue in patients with coronary heart disease
or endocarditis.51,45
Three physiopathological mechanisms were suggested
for the interaction between periodontal disease and sys-
temic diseases such as CVD.52 The first mechanism is
related to the secretion of in situ pro-inflammatory markers
(interleukin 1 [IL-1], IL-6, and tumor necrosis factor-a
[TNFa]) caused by the presence of periodontal pathogens
such as Pg, Tannerella forsythensis (Tf), Treponema denti-
cola (Td), Prevotella intermedia (Pi), or their virulence
factors inside the periodontal tissues. This can lead to an
increased systemic inflammatory status that would potenti-
ate CVD.53 The second process is associated with the pas-
sage of oral bacteria or their by-products into the
bloodstream. The third physiopathological pathway is con-
nected with the migration of periodontal bacteria through
the bloodstream and their invasion into locus minoris resis-
tentiae (LMR) of local endothelium loss and platelet aggre-
gation.51,54 For phylogenic reasons (coagulation and
immunity are common pathways in invertebrates), bacteria
have more affinity for intravascular thrombus than for other
tissues within a higher organism.55,56 Once bacteria have
colonized the thrombus, local innate immune cascade,
including neutrophil extracellular traps (NETs),57 with subsequent
disease progression.58,59
Although these pathways have been well documented for
the development of atherothrombosis (ATH), the role of peri-
odontal disease as an additional risk of the progression of AAA
specifically remains poorly explored.45,60-65 Even though ATH
and AAA have similarities in their pathogenesis, additional
synergetic or independent factors such as increased hemody-
namic force, hypercholesterolemia, or genetics promotes the
AAA. Moreover, it has also been proposed that specific infec-
tion by Chlamydia pneumoniae plays a significant role in the
AAA progression.66-68
Therefore, it is of interest to independently assess the influ-
ence of periodontitis and periodontal-specific bacteria on AAA
development. The aim of the present systematic review was to
investigate the current knowledge about the influence of peri-
odontitis on AAA to answer the key question, “Does period-
ontal disease influence the progression of AAA?”
Materials and Methods
Study Design
The present study was designed as a systematic review focus-
ing on the relationship between AAA and periodontitis. The
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses for Network Meta-analyses checklist and guidelines
for systematic review were followed.69 All studies involving
AAA and periodontitis were assessed. Due to a limitation of
data in humans, animal studies were also included.
Focused Question and Search strategy
The controlled vocabulary (MeSH terms) and free keywords in
the search strategy were defined based on the following focus
question and PECO framework (P: population, E: exposure, C:
control, O: outcome)70: “Does periodontitis influence the pro-
gression of abdominal aortic aneurysms”? This question is
addressed according to the following criteria:
 Population: Animals or humans or both presenting AAA
 Exposure: Exposed to periodontitis or periodontal
pathogens
 Control: Not exposed to periodontitis or periodontal
pathogens
 Outcome: AAA growth, expansion, rupture, or
progression
The search algorithm is shown in Table 1. An electronic
search of the literature was performed using PubMed/MED-
LINE and Embase. Selected publications were collected in
Reference Manager software (Endnote X7, Thomson Reuters,
New York, New York) until June 2017; duplicates were dis-
carded electronically. In addition, a manual search was carried
out on the reference lists of all potentially eligible studies
obtained as full text.
Study Selection and Statistical Analysis
Two independent reviewers (L.S. and D.V.) screened titles,
then abstracts, and finally full texts of all articles identified
by the electronic and manual searches. The level of agreement
Table 1. Algorithm for Electronic Search.
(((((((((“periodontitis”) OR “periodontal pathogen”) OR “dental
plaque”) OR “porphyromonas gingivalis” [MeSH Terms]) OR
“aggregatibacter actinomycetemcomitans” [MeSH Terms]) OR
“prevotella intermedia” [MeSH Terms]) OR “treponema denticola”
[MeSH Terms]) OR “tannerella forsythia” [MeSH Terms]) AND
“aortic aneurysm, abdominal” [MeSH Terms]) OR ((“abdominal
aortic aneurysm expansion” OR “abdominal aortic aneurysm
growth” OR “abdominal aortic aneurysm progression” OR
“abdominal aortic aneurysm rupture” OR “abdominal aortic
aneurysm thrombosis” OR “abdominal aortic aneurysm
thrombus”))
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between the reviewers was calculated using the Cohen k coef-
ficient at each level of selection.
To enhance sensitivity, records were removed only if both
reviewers excluded them based on the titles. In case of dis-
agreements, a discussion with a third reviewer (F.L.) resolved
the issue. The selection was done according the inclusion and
exclusion criteria (see below). No statistical meta-analysis was
performed, but in studies, a P < .05 was considered significant.
Assessment of Study Quality
Quality assessments were performed according to the
AMSTAR methodological quality assessment of systematic
reviews71 (Supplementary Appendix II). Each animal or
human study was rated independently based on its quality
by 2 reviewers, using the criteria outlined in the Systematic
Review Centre for Laboratory Animal Experimentation
Office of Health Assessment72 and Translation (risk of bias)
tool.73 The tool contains 10 entries that are related to selec-
tion bias, performance bias, detection bias, attrition bias,
reporting bias, and other biases (Supplementary Appendix
III and IV).72
Inclusion and Exclusion Criteria
The inclusion criteria were (1) animal or human studies, (2)
studies focusing on the relationship between periodontitis and
AAA growth or progression or expansion or rupture or throm-
bosis, (3) in vivo studies, and (4) randomized controlled clin-
ical trials, case–control studies, prospective clinical series, and
retrospective studies.
The exclusion criteria were (1) literature reviews, (2) editor-
ials, (3) studies involving AAA not related to periodontitis, (4)
studies involving the relationship between periodontitis and
CVDs but not specifically AAA, and (5) studies involving
AAA treatment.
Data Extraction
All selected studies were read carefully to identify the follow-
ing data.
For human studies:
 Author(s) and year of publication
 Study design
 Objectives of the study
 Number and origin of the AAA biopsy in the test and
control groups
 Methods for periodontitis identification and
characterization
 Periodontitis prevalence and type and proportion of
the pathogens
 Size of the aortic diameter or size of the thrombus
 Detection of local inflammation in the vascular wall or
in the thrombus
 Retrieved periodontal DNA in the vascular wall
 Conclusion of the authors
For animal studies:
 Author(s) and year of publication
 Animals species and variety
 Experimental model/aneurysm induction method
 Objectives of the study
 Type of periodontal pathogens
 Study design and groups distribution
 Size of the AAA diameter
 Plasmatic inflammatory biomarkers
 Detection of local inflammation in the vascular wall or
in the thrombus
 Retrieved periodontal DNA in the vascular wall
 Conclusion of the authors
In cases of missing data, the authors were contacted by
e-mail to collect the information.
Results
Search and Selection
The search strategy and selected publications are shown in
Figure 1 and Tables 2 and 3. The Embase and PubMed search
strategy resulted in 297 articles. After screening the titles, 289
(97.3%) and 288 (97.0%) were excluded, respectively, by the
first and second reviewers, resulting in a Cohen k coefficient of
.94 (95% confidence interval, 0.82-1.0). Nine titles were
selected for abstract reading, of which 3 were excluded (k ¼
1.0). After full-text assessments, 1 article was additionally
excluded. Finally, both reviewers agreed to include 5 articles
in the systematic review. The studies excluded and the reasons
for exclusion are reported in Supplementary Appendix I. Five
articles were found eligible for a systematic review, but a meta-
analysis could not be performed due to the heterogeneity of the
studies.
Study Characteristics
There was substantial heterogeneity between studies in terms
of study design. One study was a human observational study,65
1 ex vivo human study,62 2 were ex vivo animal studies,60,74
and 1 study involved ex vivo samples from both animals and
humans.75 The relationship between AAA and periodontitis
was explored in several ways: correlating clinical periodontal
measurements with the presence of AAA,65 bacterial detection
by polymerase chain reaction (PCR) in different fluids (saliva,
subgingival plaque, blood) or in the aneurysm,62,75,64 immuno-
histochemical analyses,74 and analysis of the AAA vol-
ume.74,60,75 An attempt was made to present a qualitative
report for both clinical and preclinical studies. Details are pre-
sented in Tables 2 and 3.
In a clinical study,66 investigating the incidence and the
severity of periodontitis in patients with AAA versus patients
with non-AAA CVD (myocardial ischemia, arrhythmia, heart
failure, and valvular disease), the authors observed that patients
affected by AAA presented a more severe periodontitis (deeper
mean pocket depth) than those without AAA. However, they
Salhi et al 3
found similar periodontal bacteria in saliva and subgingival
plaque samples for the 2 groups. The authors concluded that
periodontitis may have a stronger influence on the progression
of AAA than on other CVDs. In another clinical study,62 all
patients with AAA presented with periodontitis. Clinical eva-
luations revealed that the periodontitis was moderate in 22% of
patients (7/32), severe in 63% of patients (20/32), and 16% of
the patients (5/32) were edentulous. Periodontal bacteria were
found in 88% of their oral samples (saliva or subgingival pla-
que or both), and most of the detected pathogens were Pg
(81%), followed by Tf (72%), Td (59%), Pi (41%), Campylo-
bacter rectus (34%), Prevotella nigrescens (19%), and Actino-
bacillus actinomycetemcomitans (3%). The authors concluded
that all patients with AAA had poor periodontal conditions
from clinical and microbiological points of view.
In 3 preclinical studies60,74,75 in rats or mice, the intravenous
(IV) or subcutaneous (SC) injection of Pg led to a significant
increase in the abdominal aortic diameter or to an expansion of
the ILT (P < .03 for mice and P < .05 for rat studies). In the
clinical part of their study, Delbosc et al75 highlighted a sig-
nificant correlation between Pg antibodies and the AAA dia-
meter and its thrombus volume (r ¼ 0.731, P < .0001). The 4
studies concluded that Pg infection was linked to the growth of
the AAA.
The physiopathological pathways of how periodontitis may
influence AAA pathogenesis were explored in 3 preclinical and
2 clinical studies. The possible relationship between the 2 dis-
eases involves the presence of systemic periodontal pathogens
leading to (1) an increase in plasmatic inflammatory and
immunologic biomarkers, (2) a local innate and adaptive pro-
cess in the AAA thrombus and wall, and (3) retrieval of period-
ontal bacterial DNA in AAA lesions.
Increase in plasma-free DNA and proteases and immunologic
biomarkers. In 2 preclinical studies,74,75 repeated SC or IV
injections of Pg in mice and rats induced an elevated level of
nonspecific periodontal biomarkers such as MMP-2, MMP-9,
and cell-free DNA (cf-DNA). In the ILT of rats that received
IV Pg injections, an increase in plasma cf-DNA (P < .0001)
indicating the presence of the NETs was observed.75 From
these results, the authors concluded that systemic neutrophil
diapedesis within the ILT,76,77 a recognized risk factor for the
development of AAA, can be induced by periodontal bacteria
and may promote AAA progression. In addition, in a clinical
study, Pg antibodies and cf-DNA were found in the plasma of
patients with AAA.75 The authors noted the consistent correla-
tion between these biomarkers and AAA diameter and throm-
bus volume. The 3 studies concluded that Pg induces local
accumulation of neutrophils and may initiate or accelerate the
growth of the AAA.
Local inflammatory process in the AAA wall or thrombus. In 3 pre-
clinical studies in mice or rats, the inoculation of Pg induced
the destruction of the abdominal aortic ECM due to local
response to Pg trapping inside the ILT and AAA wall conse-
quences, involving the fragmentation of the elastic fibers
(P < .05) by metalloproteases MMP-2 and MMP-960,75,78 and
serine proteases (leukocyte elastase, u-PA, cathepsin G,
Figure 1. Diagram of article selection process–Search strategy.
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plasmin).79,80 In 2 of these preclinical studies75,78 and 1 clinical
study,76 an increased number of inflammatory cells, namely,
CD-8, neutrophil (NET), and cf-DNA as well as Pg antibodies,
were found in the aneurysmal wall and in the ILT. The 4 studies
concluded that Pg seems to promote the progression of the
AAA through increasing inflammation in the wall or in the
thrombus of the AAA.
Retrieval of periodontal bacteria DNA in AAA lesions. In the ex vivo
analyses of human AAA, 2 authors62,75 found genetic material
Table 2. Results Preclinical Studies.
Aoyama et al60 Delbosc et al75 Aoyama et al74
Animal model Mice (type: C57BL) Rats (type: Lewis) Mice (type: C57BL/wild-type,
or TLR2 KO or TLR4 KO)
Aneurysm induction
method
Application of 0.25 M CaCl2 Implantation of a segment of sodium
dodecyl sulfate-decellularized pig
aorta
Application of 0.25 M CaCl2
Periodontal bacterial
infection
Pg or Aa subcutaneous (SC) injections Pg intravenous (IV) injections Pg SC injections
Study design - Test group: 29 AAA - Test group:9 AAA - Test group: AAA (n ¼ NA)
Injections of Pg, Aa, or PBS Injection of Pg Injections of Pg or PBS
- Control group: 39 non-AAA - Control group:11 AAA - Control group: non-AAA (n
¼ NA)
Injections of Pg, Aa or PBS Injection of saline solution Injections of Pg or PBS
Objectives Observe the influence of Pg and Aa on the:
- AAA dilatation
- In situ CD-8 and MMPs levels
Observe the influence of Pg on the:
- AAA dilatation
- Neutrophil retention (NET)
- Persistence of intraluminal
thrombus (ILT)
Observe the influence of Pg
on the:
- AAA dilatation
- Role of TLR2 and TLR4
- Plasmatic and in situ MMPs
levels
Results
Size of the AAA
diameter
- Increase in mice infected with Pg (P < .05)
- No increase in mice infected with Aa (NS)
- Increase in rats infected with Pg (P <
.03)
- No increase in rat injected with
saline solution (NS)
- Increase in mice infected





NA The cell-free DNAwas detected in the
plasma of Pg-infected mice and was
correlated to the NET in the ILT (P
< .0001)
The MMP-9 level increased in
the plasma of TRL4/ Pg-
infected mice (P < .05)
Local inflammatory
process in the AAA
wall or thrombus
- The AAA wall of the Pg-infected mice
showed a significant destruction of their
elastic fibers (P < .05)
- The AAA wall of the Pg-infected mice
harbored a higher number of CD-8 than
noninfected mice (P < .05)
- The aortic wall of the Pg-infected mice
presented higher levels of MMP-2 than
noninfected mice (P < .05)
- The ILT of Pg-infected rat exhibited a
significant enrichment in
neutrophils
- The AAA wall and the thrombus of
the Pg-infected rats showed an
increase activity of MMP-9 (P < .01)
- The AAA wall of the Pg-
infected mice showed a
destruction of their elastic
fibers.
- The AAA wall of Pg-infected
mice presented higher
level of MMP-2 and MMP-9
- The elastic fibers and the









Conclusions - Pg seems to accelerate or initiate the
progression of AAA through the
increased expression of MMPs from
infiltrating inflammatory cells.
- Similar results were not found with Aa
- Pg fostered aneurysm development
and Pg was associated with the
persistence of neutrophil-rich
luminal thrombus




- Pg infection leads to MMP-2
and MMP-9 upregulation in
the AAA wall
Abbreviations: Aa, Actinobacillus actinomycetemcomitans; AAA, abdominal aortic aneurysm; KO, knockout; MMP, matrix metallopeptidase; NA, not applicable; NET,
neutrophil extracellular trap; PBS, phosphate-buffered saline; Pg, Prophyromonas gingivalis; TLR, Toll-like receptor.













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































of periopathogens and antibodies specific to periodontal bac-
teria or Pg-lipopolysaccharide (Pg-LPS) in AAA thrombi or in
the aneurysmal wall. The authors concluded that periodontal
bacteria contribute directly to weakening the aneurysmal wall
and that the prevention or the treatment of periodontitis may
limit AAA progression.
Discussion
Periodontitis is a chronic inflammatory disease caused by den-
tal plaque, more specifically by gram-negative anaerobic bac-
teria accumulation in periodontal pockets. The bacterial
species forms a bacterial complex described by Socransky19;
among them, the orange and the red clusters are specific for
periodontitis. The red one involves Td, Pg, and Tf, and the
orange bacterial association is characterized by Fusobacterium
nucleatum and Pi. Inside this complex, bacteria exchange nutri-
ents, virulence factors and/or factors of resistance such as cyto-
toxins, proteases, hemagglutinin, and LPS were able to
neutralize local host defenses.81,82 Therefore, the imbalance
between host–parasite interactions participates in disease pro-
gression.83,84 Moreover, due to mastication and tooth brushing,
these specific pathogens or their endotoxins can reach the sys-
temic blood circulation,85,86 where they are destroyed by the
reticuloendothelial system, or they colonize different intravas-
cular sites such as the LMR.52,87,88 The consequences of these
metastatic infections are an augmentation of host inflammation
and influence the development of systemic diseases such as
CVDs, diabetes, and preterm birth.89-93
As demonstrated, Pg participates in the CVD progression
due to its fixation on the atheroma as LMR.47,48,50,94-96 These
particular anaerobic, cram-negative bacteria can aggregate in
red blood cells due to its capacity of hemagglutination97,98;
they also affect blood cholesterol levels99-104 and therefore
participate in thrombosis. Already in 2009, Paraskevas
et al105 in a literature review considered the possible mechan-
isms involved between AAA and periodontitis, namely, the
role of the inflammatory response and the effect on periodontal
pathogens in the tissues of the host.
The present systematic review highlighted AAA as LMR for
periodontal pathogens and how periodontal bacteria could par-
ticipate in this particular CVD progression. To interpret the
association between the 2 diseases, it is prudent to emphasize
certain aspects of AAA pathogenesis. The disease involves a
thinner arterial wall with (1) the production of circulating cyto-
kines (IL-1, IL-6, and TNFa), MMPs, and serine proteases with
high proteolytic activity; (2) the destruction of the structural
matrix proteins, the loosening of elastic fibers, and the deple-
tion of smooth-muscle cells; and (3) the increased amount of
neutrophil in the ILT.6,106-122
The selected articles highlighted the implication of period-
ontitis on the ATH progression with ILT and the aortic wall as
key places. The Pg DNA was detected by PCR on human
aneurysmal samples,75,62 mainly in the thrombus and in the
wall of the aneurysm. This corroborates the fact that the anae-
robic bacteria can be transported by blood circulation and then
can reach the ILT due to its direct connection with the lumen of
the vessel and also the wall of AAA. It was also suggested that
Toll-like receptors (TLR-2 and TLR-4) may play a role in the
AAA inflammatory process by their specific recognition of
gram-negative bacteria LPS, such as Pg.123 These TLRs, found
on endothelial cells, participate to increase the activation of
kinases such as nuclear factor-kB and therefore induce the
cytokines activation, such as TNFa and IL-6, resulting in the
high inflammatory activity inside the AAA wall. The mechan-
ism of bacterial invasion on the endothelial ILT seems to
involve fimbriae, specific of Pg,124,125 and therefore would
explain the Pg DNA detection on the aneurysm samples. The
consequences of Pg fimbriae anchorage would induce the
expression of IL-8 and chemoattractive monocytes126-128 and
therefore would participate in the increased amount of neutro-
phil found in the ILT as LMR (Figure 2). As demonstrated,75
Pg promotes the formation of NETs on the interface between
the thrombus and the blood circulation with, as a consequence,
the increase in the volume of the ILT, which stimulates the
AAA growth and size. It can be assumed that the severity of
periodontitis characterized by bacterial burden (quantity of
periopathogens) may influence the AAA expansion. Therefore,
it would be expected that patient with AAA with severe period-
ontitis would be more exposed to bacterial penetration in the
bloodstream and more susceptible for the AAA progression
compared with patients presenting mild periodontitis.
As mentioned, the disease progression also involves the
destruction of elastic fibers and a high protease activity. The
selected preclinical studies highlighted more elastolysis,60,74
the colonization of the abdominal aortic wall, and the ILT by
inflammatory cells (CD-8, neutrophils) and a higher proteolytic
activity in cases of Pg infection compared with the non-Pg-
infected controls.75 In these studies, the aortic wall of Pg-
infected animals presented higher level activity of MMP-9,
suggesting more proteolytic activities and neutrophil attraction
in the luminal layer of the ILT.116,122 Moreover, Pg infection
Figure 2. Locus minoris resistentiae (LMR) in intraluminal thrombus
(ILT). Typical aspect of a LMR surrounded by a neutrophil crown
(arrows). Within in ILT in human AAA (DAPI 20). AAA indicates
abdominal aortic aneurysm.
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involved a significant increase in myeloperoxidase-DNA com-
plexes in both plasma and aneurysm samples,75 inducing oxi-
dative stress, which participates in AAA pathogenesis, namely,
by contribution to the dysregulation of MMPs and the apoptosis
of smooth-muscle cells.117,129,130
Despite the limited number of available studies dealing with
the relationship between AAA and periodontitis, the present
systematic review suggests that the presence of periodontal
bacteria in the bloodstream or in situ in the vascular lesion is
a risk associated with aneurysmal disease progression.
In order to establish the relationship between these 2 chronic
inflammatory diseases, further evidence is needed. Cross-
sectional studies correlating the AAA size with the severity
of periodontitis would be of interest. Moreover, prospective
multicenter study on large cohort and further exploration of
surgically retrieved aneurysms should be considered.
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